ProfileGDS4459 / ENSG00000054282
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 72% 72% 79% 70% 82% 78% 76% 81% 79% 69% 79% 78% 78% 74% 75% 77% 75% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.3472
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.372
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.0979
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.2670
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.3982
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.9178
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.8376
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.3381
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.1579
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.3369
GSM623474group B, liver allograft wedge biopsie placebo treatment 1679
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.0778
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.9578
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.4274
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.8175
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.6877
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.5675